0.1524
price down icon21.52%   -0.0576
 
loading
Schlusskurs vom Vortag:
$0.21
Offen:
$0.145
24-Stunden-Volumen:
11,517
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.08M
KGV:
-0.00443
EPS:
-34.43
Netto-Cashflow:
$-11.54M
1W Leistung:
-21.52%
1M Leistung:
-80.61%
6M Leistung:
-86.27%
1J Leistung:
-97.18%
1-Tages-Spanne:
Value
$0.145
$0.154
1-Wochen-Bereich:
Value
$0.145
$0.154
52-Wochen-Spanne:
Value
$0.145
$0.154

Bio Path Holdings Inc Stock (BPTH) Company Profile

Name
Firmenname
Bio Path Holdings Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
BPTH's Discussions on Twitter

Vergleichen Sie BPTH mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BPTH
Bio Path Holdings Inc
0.1524 0 0 -16.08M -11.54M -34.43
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-03-11 Eingeleitet ROTH Capital Buy
2017-11-13 Bestätigt H.C. Wainwright Buy
2016-08-10 Bestätigt Maxim Group Buy
2016-04-18 Eingeleitet Rodman & Renshaw Buy
2014-06-02 Fortgesetzt Maxim Group Buy
2014-05-09 Eingeleitet Maxim Group Buy
Alle ansehen

Bio Path Holdings Inc Aktie (BPTH) Neueste Nachrichten

pulisher
Aug 02, 2025

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Update - Defense World

Aug 02, 2025
pulisher
Jul 31, 2025

Tevogen Bio Holdings Inc. stock trend outlook and recovery pathFree Long Hold Safe Return Strategy - Newser

Jul 31, 2025
pulisher
Jul 29, 2025

Adicet Bio Inc. stock trend outlook and recovery pathLow Risk Picks for Daily Trading Released - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Cutaneous T-Cell Lymphoma Pipeline Outlook Report 2025: Key 25+ Companies and Breakthrough Therapies Shaping the Future Landscape - The Globe and Mail

Jul 28, 2025
pulisher
Jul 28, 2025

TOPAZ REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS DEMONSTRATING STRONG ROYALTY AND INFRASTRUCTURE GROWTH - The Globe and Mail

Jul 28, 2025
pulisher
Jul 28, 2025

Cutaneous T-Cell Lymphoma Pipeline Outlook Report 2025: Key 25+ Companies And Breakthrough Therapies Shaping The Future Landscape - Menafn.com

Jul 28, 2025
pulisher
Jul 25, 2025

Antisense & RNAi Therapeutics Market Outlook 2025-2033: - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

The Zacks Analyst Blog Highlights Meta Platforms, Alphabet, Microsoft and Tesla - The Globe and Mail

Jul 25, 2025
pulisher
Jul 25, 2025

Antisense & RNAi Therapeutics Market Outlook 2025-2033: Advancements in Drug Delivery Propel Growth with Revenues Forecast to Reach $3.3 Billion by 2033 - Yahoo Finance

Jul 25, 2025
pulisher
Jul 24, 2025

Tucows Announces Timing for Q2 2025 Financial Results News Release and Management Commentary - The Globe and Mail

Jul 24, 2025
pulisher
Jul 24, 2025

Meta Platforms Is Helping Power This 6%-Yielding Dividend Stock's Continued Growth - The Globe and Mail

Jul 24, 2025
pulisher
Jul 23, 2025

Google's AI push pays off with solid second quarter, but doubts about company's future persist - The Globe and Mail

Jul 23, 2025
pulisher
Jul 23, 2025

Tevogen Bio Holdings Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Tevogen Bio Holdings Inc. stockFree Predictions - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Cutaneous T-cell Lymphoma Market Anticipates Impressive - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Cutaneous T-cell Lymphoma Market Anticipates Impressive Growth Trajectory at a CAGR of 7.1% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

Cutaneous T-cell lymphoma Clinical Trials 2025: EMA, PDMA, FDA - openPR.com

Jul 21, 2025
pulisher
Jul 21, 2025

Cutaneous T-cell lymphoma Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism of Action, Route of Administration, and Companies by DelveInsight - Barchart.com

Jul 21, 2025
pulisher
Jul 21, 2025

Freeport-McMoRan to Post Q2 Earnings: What's in Store for the Stock? - The Globe and Mail

Jul 21, 2025
pulisher
Jul 20, 2025

What drives Tevogen Bio Holdings Inc. stock priceFree Stock Selection - printweek.in

Jul 20, 2025
pulisher
Jul 18, 2025

Carvana Is Up 100x Since the 2022 Lows. Could This Stock Be Next? - The Globe and Mail

Jul 18, 2025
pulisher
Jul 17, 2025

Mullen Announces Plan to Change Company’s Name to Bollinger Innovations, Inc. and NASDAQ Approval for New Symbol — BINI - The Globe and Mail

Jul 17, 2025
pulisher
Jul 16, 2025

Antisense Oligonucleotide Therapeutics Pipeline Appears - openPR.com

Jul 16, 2025
pulisher
Jul 15, 2025

Antisense Oligonucleotide Therapeutics Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Jul 15, 2025
pulisher
Jul 15, 2025

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight - PR Newswire UK

Jul 15, 2025
pulisher
Jul 15, 2025

Antisense Oligonucleotide Therapeutics Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight - Menafn.com

Jul 15, 2025
pulisher
Jul 14, 2025

Oligonucleotides Competitive Landscape 2025: 320+ Therapies - openPR.com

Jul 14, 2025
pulisher
Jul 14, 2025

Waldenstrom Macroglobulinemia Market Sees Surging Demand - GlobeNewswire

Jul 14, 2025
pulisher
Jul 14, 2025

Waldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight - Business Upturn

Jul 14, 2025
pulisher
Jul 14, 2025

Massive $888M Deal: Biotech Firm Makes Historic Pivot to Become Largest US Public HYPE Token Holder - Stock Titan

Jul 14, 2025
pulisher
Jul 14, 2025

Where Will Arista Networks Be in 5 Years? - The Globe and Mail

Jul 14, 2025
pulisher
Jul 08, 2025

30 Billion Reasons to Buy Oracle Stock Like There's No Tomorrow - The Globe and Mail

Jul 08, 2025
pulisher
Jul 07, 2025

Top 5 AI Growth Stocks to Buy in July 2025 - The Globe and Mail

Jul 07, 2025
pulisher
Jul 03, 2025

Delisting of Securities from The Nasdaq Stock Market - The Manila Times

Jul 03, 2025
pulisher
Jun 24, 2025

Bio-Path Holdings announces executive resignations and operational pause - Investing.com

Jun 24, 2025
pulisher
Jun 24, 2025

Bio-Path Holdings Faces Leadership Changes and Operational Pause, Considers Strategies Amid Limited Capital - AInvest

Jun 24, 2025
pulisher
Jun 20, 2025

Bio-Path Holdings Faces Leadership Changes and Operational Pause - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Cutaneous T Cell Lymphoma Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Barchart.com

Jun 17, 2025
pulisher
Jun 17, 2025

Oligonucleotides Clinical Trial Pipeline Analysis Demonstrates 280+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight - SINA HONG KONG LIMITED

Jun 17, 2025
pulisher
Jun 13, 2025

Life Sciences Investor Forum: Now Available for Online Viewing - The Manila Times

Jun 13, 2025
pulisher
Jun 12, 2025

GitLab (NASDAQ:GTLB) Given New $60.00 Price Target at Wells Fargo & Company - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

GRI Bio’s (GRI) Buy Rating Reaffirmed at HC Wainwright - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Short Interest in Bitcoin Depot Inc. (NASDAQ:BTMWW) Expands By 5,350.0% - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

GitLab (NASDAQ:GTLB) Price Target Cut to $52.00 by Analysts at JPMorgan Chase & Co. - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Short Interest Up 870.6% in May - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Cuts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Reduces Stock Holdings in Industrial Logistics Properties Trust (NASDAQ:ILPT) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Two Sigma Investments LP Makes New $273,000 Investment in ORIX Co. (NYSE:IX) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Is Howmet Aerospace Stock Outperforming the S&P 500? - The Globe and Mail

Jun 12, 2025
pulisher
Jun 11, 2025

Life Sciences Investor Forum Agenda Announced for June 11th-12th - GlobeNewswire

Jun 11, 2025
pulisher
Jun 09, 2025

Bio-Path Holdings to Present at Life Sciences Virtual Investor F - GuruFocus

Jun 09, 2025

Finanzdaten der Bio Path Holdings Inc-Aktie (BPTH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Kapitalisierung:     |  Volumen (24h):